| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Marja-Riitta Taskinen | Q18246437 |
| P2093 | author name string | Jan Borén | |
| Chris J Packard | |||
| P2860 | cites work | Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome | Q92354069 |
| Long-Term Consumption of Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Mortality in US Adults | Q92434973 | ||
| From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis | Q92694745 | ||
| Role of apolipoprotein C-III overproduction in diabetic dyslipidaemia | Q93019346 | ||
| Fructose at the crossroads of the metabolic syndrome and obesity epidemics | Q93368996 | ||
| Fructose consumption as a risk factor for non-alcoholic fatty liver disease | Q24657933 | ||
| Uric acid in metabolic syndrome: From an innocent bystander to a central player | Q26772053 | ||
| Fructose consumption: recent results and their potential implications | Q27968226 | ||
| Sugar consumption, metabolic disease and obesity: The state of the controversy | Q27968233 | ||
| Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease | Q28072381 | ||
| Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease? | Q28077776 | ||
| Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome | Q28251719 | ||
| High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study | Q28474831 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Transport, metabolism, and endosomal trafficking-dependent regulation of intestinal fructose absorption | Q28509620 | ||
| Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults | Q29614911 | ||
| Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review. | Q30234756 | ||
| The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis | Q30249128 | ||
| Obesity and cardiovascular disease: friend or foe? | Q30251999 | ||
| Health Effects of Overweight and Obesity in 195 Countries over 25 Years | Q30402965 | ||
| Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey | Q30572017 | ||
| More pieces of the fructose puzzle | Q33365632 | ||
| Sweetened beverage consumption and the risk of hyperuricemia in Mexican adults: a cross-sectional study. | Q33624712 | ||
| Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study. | Q33693601 | ||
| Impact of fat mass and distribution on lipid turnover in human adipose tissue | Q33759091 | ||
| Expression of fatty acid synthase in nonalcoholic fatty liver disease. | Q33962008 | ||
| Sugar, uric acid, and the etiology of diabetes and obesity. | Q34038315 | ||
| Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. | Q34056163 | ||
| Metabolic effects of fructose and the worldwide increase in obesity. | Q34093669 | ||
| Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study | Q34113313 | ||
| Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study | Q34206710 | ||
| The effects of fructose intake on serum uric acid vary among controlled dietary trials. | Q34211386 | ||
| Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. | Q34406791 | ||
| A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults | Q34473275 | ||
| Fructose and Cardiometabolic Health: What the Evidence From Sugar-Sweetened Beverages Tells Us. | Q34496535 | ||
| Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study | Q34587900 | ||
| Caloric sweetener consumption and dyslipidemia among US adults | Q34607557 | ||
| Fructose metabolism in humans - what isotopic tracer studies tell us. | Q34643422 | ||
| Fructose-rich beverages and risk of gout in women | Q34684242 | ||
| Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. | Q35020145 | ||
| De novo lipogenesis in metabolic homeostasis: More friend than foe? | Q35573584 | ||
| Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women | Q35656105 | ||
| Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat. | Q35680888 | ||
| Uric Acid Levels Can Predict Metabolic Syndrome and Hypertension in Adolescents: A 10-Year Longitudinal Study | Q35855406 | ||
| Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies | Q36099467 | ||
| Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes | Q36120653 | ||
| Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans | Q36295250 | ||
| Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver | Q36335957 | ||
| Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. | Q36418940 | ||
| Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts | Q36787024 | ||
| Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease | Q36818384 | ||
| Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms | Q36867126 | ||
| Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans | Q37170824 | ||
| Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction | Q37179529 | ||
| Causes and metabolic consequences of Fatty liver | Q37250791 | ||
| Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents | Q37306785 | ||
| Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis | Q37337488 | ||
| ChREBP regulates fructose-induced glucose production independently of insulin signaling | Q37395843 | ||
| A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. | Q37571422 | ||
| Serum uric acid: A strong and independent predictor of metabolic syndrome after adjusting for body composition. | Q51287419 | ||
| Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. | Q51343064 | ||
| Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. | Q51467220 | ||
| Epidemiology of non-alcoholic fatty liver disease. | Q51566234 | ||
| Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. | Q51608142 | ||
| Higher consumption of sugar-sweetened soft drinks increases the risk of hyperuricemia in Korean population: The Korean Multi-Rural Communities Cohort Study. | Q53306109 | ||
| Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. | Q53307617 | ||
| Intestinal microbiota in patients with nonalcoholic fatty liver disease. | Q54317263 | ||
| Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 | Q56379571 | ||
| Fructose-containing caloric sweeteners as a cause of obesity and metabolic disorders | Q56610848 | ||
| Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects | Q56981583 | ||
| Low-Calorie Sweetened Beverages and Cardiometabolic Health: A Science Advisory From the American Heart Association | Q57823538 | ||
| Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars | Q58121796 | ||
| Non-Alcoholic Fatty Liver Disease-A Global Public Health Perspective | Q58583391 | ||
| Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease | Q58787282 | ||
| Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism | Q58795278 | ||
| Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy | Q60358131 | ||
| EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | Q60462090 | ||
| Effects of Dietary Protein and Fat Content on Intrahepatocellular and Intramyocellular Lipids during a 6-Day Hypercaloric, High Sucrose Diet: A Randomized Controlled Trial in Normal Weight Healthy Subjects | Q61812624 | ||
| Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial | Q61862450 | ||
| Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans | Q62745793 | ||
| French Recommendations for Sugar Intake in Adults: A Novel Approach Chosen by ANSES. | Q64987278 | ||
| Fructose-induced hyperuricaemia | Q70076003 | ||
| Prevalence of the metabolic syndrome in individuals with hyperuricemia | Q80233374 | ||
| Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study | Q83505457 | ||
| Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease | Q86861780 | ||
| Dietary Fructose Metabolism By Splanchnic Organs: Size Matters | Q87990953 | ||
| Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management | Q88182023 | ||
| Dietary carbohydrates and fatty liver disease: de novo lipogenesis | Q88480846 | ||
| Intestinal Absorption of Fructose | Q88643832 | ||
| Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis | Q88673490 | ||
| Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories | Q88674656 | ||
| Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease | Q89235898 | ||
| Relevance of human fat distribution on lipid and lipoprotein metabolism and cardiovascular disease risk | Q89561656 | ||
| NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology | Q89927147 | ||
| Sugar-Sweetened Soft Drinks and Fructose Consumption Are Associated with Hyperuricemia: Cross-Sectional Analysis from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) | Q90639327 | ||
| Metabolic health in normal-weight and obese individuals | Q90655318 | ||
| Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome | Q90773779 | ||
| Dietary Fructose and Microbiota-Derived Short-Chain Fatty Acids Promote Bacteriophage Production in the Gut Symbiont Lactobacillus reuteri | Q91116091 | ||
| The extra-splanchnic fructose escape after ingestion of a fructose-glucose drink: An exploratory study in healthy humans using a dual fructose isotope method | Q91129047 | ||
| Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies | Q91264430 | ||
| Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis | Q91281547 | ||
| Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps | Q91400289 | ||
| Sugar and Fatty Acids Ack-celerate Prophage Induction | Q91580536 | ||
| Application of Magnetic Resonance Spectroscopy in metabolic research | Q91812670 | ||
| Obesity: global epidemiology and pathogenesis | Q91986696 | ||
| Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review | Q92018699 | ||
| Intestinal lipogenesis: how carbs turn on triglyceride production in the gut | Q92153213 | ||
| Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD | Q92179878 | ||
| Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review | Q37710429 | ||
| Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia | Q37727252 | ||
| Dietary fructose in nonalcoholic fatty liver disease | Q38079794 | ||
| The unfolded protein response in fatty liver disease | Q38162132 | ||
| Biology of upper-body and lower-body adipose tissue--link to whole-body phenotypes. | Q38264613 | ||
| Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies | Q38574048 | ||
| Sweet Sixteenth for ChREBP: Established Roles and Future Goals | Q38648009 | ||
| Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity. | Q38761767 | ||
| A possible role of serum uric acid as a marker of metabolic syndrome | Q39127912 | ||
| Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population | Q39693472 | ||
| High serum uric acid levels increase the risk of metabolic syndrome in elderly women: The PRO.V.A study | Q40236749 | ||
| Added Sugars Intake Across the Distribution of US Children and Adult Consumers: 1977-2012. | Q41644906 | ||
| Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease | Q41770716 | ||
| Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease | Q41986990 | ||
| Dicarbonyl stress in clinical obesity | Q42273415 | ||
| Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease. | Q42368231 | ||
| Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. | Q43059708 | ||
| Effects of a short-term overfeeding with fructose or glucose in healthy young males | Q43237468 | ||
| Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study | Q43979789 | ||
| Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans | Q44009597 | ||
| Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-contain | Q44031791 | ||
| Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans | Q44602540 | ||
| Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies | Q44998496 | ||
| Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome. | Q45941074 | ||
| Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. | Q46185793 | ||
| Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease | Q46215726 | ||
| Fructose and carbonyl metabolites as endogenous toxins | Q46253659 | ||
| Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. | Q46570510 | ||
| Type of supplemented simple sugar, not merely calorie intake, determines adverse effects on metabolism and aortic function in female rats | Q46570814 | ||
| Intestinal, but not hepatic, ChREBP is required for fructose tolerance. | Q47268980 | ||
| Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling | Q47708428 | ||
| Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes | Q47915943 | ||
| No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. | Q47969446 | ||
| Fructose metabolism and metabolic disease | Q49498180 | ||
| An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans. | Q49886777 | ||
| The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids. | Q50134498 | ||
| Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. | Q50147806 | ||
| Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study. | Q50455247 | ||
| Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study. | Q50862116 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P433 | issue | 9 | |
| P921 | main subject | keto-D-fructose | Q122043 |
| metabolic syndrome | Q657193 | ||
| dietary sugars | Q104972014 | ||
| P577 | publication date | 2019-08-22 | |
| P1433 | published in | Nutrients | Q7070485 |
| P1476 | title | Dietary Fructose and the Metabolic Syndrome | |
| P478 | volume | 11 |
| Q90369826 | Activated pathogenic Th17 lymphocytes induce hypertension following high-fructose intake in Dahl salt-sensitive (SS) but not Dahl salt-resistant (SR) rats |
| Q92441889 | Intestinal Fructose and Glucose Metabolism in Health and Disease |
| Q104278369 | Maternal intake of alpha-lipoic acid prevents development of symptoms associated with a fructose-rich diet in the male offspring in Wistar rats |
Search more.